The TEL gene and human leukemia

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1288, Issue 1, 1996, Pages

  Golub, Todd R ^a   McLean, Thomas ^a   Stegmaier, Kimberly ^a   Carroll, Martin ^a   Tomasson, Michael ^a   Gilliland, D Gary ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA BINDING PROTEIN; HYBRID PROTEIN; PLATELET DERIVED GROWTH FACTOR RECEPTOR; TRANSCRIPTION FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOCYTIC LEUKEMIA; CHILD; CHILDHOOD LEUKEMIA; CHROMOSOME TRANSLOCATION; CHRONIC MYELOMONOCYTIC LEUKEMIA; DNA BINDING; GENE REARRANGEMENT; GENE STRUCTURE; HUMAN; HUMAN CELL; LEUKEMOGENESIS; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW;

EID: 0030575543     PISSN: 0304419X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-419X(96)00015-7     Document Type: Review

References (27)

1. [1] Nunn, M., Seeburg, P.H., Moscovici, C. and Duesberg, P.H. (1983) Nature 306, 391-395.
2. [2] Nye, J.A., Petersen, J.M., Gunther, C.V., Jonsen, M.D. and Graves, B.J. (1990) Genes Dev. 6, 975-990.
3. [3] Siddique, H.R., Rao, V.N., Lee, L. and Reddy, S.P. (1993) Oncogene 8, 1751-1755.
4. [4] Rao, V.N., Ohno, T., Prasad, D.D.K., Bhattacharya, G. and Reddy, E.S.P. (1993) Oncogene 8, 2167-2173.
5. [5] Wasylyk, B., Hahn, S.L. and Giovane, A. (1993) The Ets family of transcription factors. Eur. J. Biochem. 211, 7-18.
6. [6] The, S.M., Xie, X., Smyth, F., Papas, T.S., Watson, D.K. and Schulz, R.A. (1992) Oncogene 7, 2471-2478.
7. [7] Watanabe, H., Sawada, J.-U., Yano, K.-I., Yamaguchi, K., Goto, M. and Handa, H. (1993) Mol. Cell. Biol. 13, 1385-1391.
8. [8] Seth, A. and Papas, T.S. (1990) Oncogene 5, 1761-1767.
9. [9] Golub, T.R., Barker, G.F., Bohlander, S.K., Hiebert, S.W., Ward, D.C., Bray-Ward, P., Morgan, E., Raimondi, S.C., Rowley, J.D. and D.G. G. (1995) Proc. Natl. Acad. Sci., in press.
10. [10] Romana, S.P., Mauchauffe, M., Leconiat, M., Chumakov, I., Le Paslier, D., Berger, R. and Bernard, O.A. (1995) Blood 85, 3662-3670.
11. [11] Raynaud, S.D., Cave, H., Baens, M., Bastard, C., Cacheux, V., Grosgeorge, J., Guidal-Giroux, C., Guo, C., Vilmer, E., Marynen, P. and Grandchamp, B. (1996) Blood 87, 2891-2899.
12. [12] Keene, P., Mendelow, B., Pinto, M.R., Bezwoda, W., MacDougall, L., Falkson, G., Ruff, P. and Bernstein, R. (1987) Br. J. Haematol. 67, 25-31.
13. [13] Srivastava, A., Boswell, H., Heerema, N.A., Nahreini, P., Lauer, R.D., Antony, A.S., Hoffman, R., Tricot, G.J. (1988) Cancer Genet. Cytogenet. 35, 61-71.
14. [14] Berkowicz, M., Rosner, E., Rechavi, C., Mamon, Z., Neuman, Y., Ben-Bassat, I. and Ramot, B. (1991) Atypical chronic myelomonocytic leukemia with eosinophilia and translocation (5;12): A new assocation? Cancer Genet. Cytogenet. 51, 277-278.
15. [15] Lerza, R., Castello, G., Sessarego, M., Cavallini, D. and Pannacciulli, I. (1992) Br. J. Haematol. 82, 476-477.
16. [16] Wessels, J.W., Fibbe, W.E., van der Keur, D., Landegent, J.E., van der Plas, D.C., den Ottolander, G.J., Roozendaal, K.J., Beverstock, G.D. (1993) t(5;12)(q31;p12) A clinical entity with features of both myeloid leukemia and chronic myelomonocytic leukemia. Cancer Genet. Cytogenet. 65, 7-11.
17. [17] Golub, T.R., Barker, G.F., Lovett, M., Gilltland, D.G. (1994) Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation. Cell 77, 307-316.
18. [18] Papadopoulos, P., Ridge, S.A., Boucher, C.A., Stocking, C. and Wiedemann, L.M. (1995) The novel activation of ABL by fusion to an ets-related gene, TEL. Cancer Res. 55, 34-38.
19. [19] Golub, T.R., Goga, A., Barker, G., Afar, D., McLaughlin, J., Bohlander, S., Rowley, J., Witte, O., Gilliland, D.G. (1996) Oligomerization of the ABL tyrosine kinase by the ETS protein TEL in human leukemia. Mol. Cell Biol., in press.
20. [20] Buijs, A., Sherr, S., van Baal, S., van Bezouw, S., van der Plas, D., van Kessel, A.D., Riegman, P., Deprez, R.L., Zwarthoff, E., Hagemeijer, A. and Grosveld, G. (1995) Oncogene 10, 1511-1519.
21. [21] Deprez, R.H.L., Riegman, P.H.J., Groen, N.A., Warringa, U.L., van Biezen, N.A., Molijn, A.C., Bootsma, D., de Jong, P.J., Menon, A.G., Kley, N.A., Seizinger, B.R. and Zwarthoff, E.C. (1995) Oncogene 10, 1521-1528.
22. [22] Romana, S.P., Piorel, H., Leconiat, M., Flexor, M.A., Mauchaffe, M., Jonveaux, P., Berger, R. and Bernard, O.A. (1995) Blood 86, 4263-4269.
23. [23] Golub, T., McLean, T., Stegmaier, K., Ritz, J., Sallan, S., Neuberg, D., Gilliland, D.G. (1995) Blood 86 (Suppl 1), 597a.
24. [24] Shurtleff, S., Buijs, A., Behm, F., Rubnitz, J., Raimondi, S., Hancock, M., Chan, G., Pui, C., Grosveld, G. and Downing, J. (1995) Leukemia 9, 1985-1989.
25. [25] Hiebert, S.W., Sun, W., Davis, J.N., Golub, T.R., Shurtleff, S., Buijs, A., J.R. D., Grosveld, G., Roussel, M., Gilliland, D.G., Lenny, N. and Meyers, S. (1996) Mol. Cell. Biol., in press.
26. [26] Duro, D., Bernard, O., Delia Valle, V., Berger, R. and Larsen, C.J. (1995) Oncogene 11, 21-29.
27. [27] Stegmaier, K., Takeuchi, S., Golub, T.R., Bohlander SK, C.R. B, Koeffler HP, Gilliland DG. (1996) Cancer Res. 56, 1413-1417.